Cullinan Therapeutics is hiring a
Principal Scientist/Associate Director

Summary

Join our team as a Senior Research Scientist to oversee and/or support early stage drug development projects in the Cullinan pipeline. You will lead contract research organizations, design program strategies, develop budget forecasts, and deliver impactful presentations. This role requires a PhD in cancer immunotherapy or related field with 1-3 years of industry experience.

Requirements

• 1-3 years of industry experience
• PhD in cancer immunotherapy, immunology, cancer biology, biological engineering, biochemistry, or a related field
• Experience in cancer and/or immunology research, preferably with experience in immuno-oncology, autoimmunity and/or protein engineering
• Experience evaluating drug asset value propositions, either in venture capital or in the biotech industry, is preferred
• Innovative thinker
• Strong attention to detail
• Highly collaborative, with an interest in working within and across teams
• Excellent verbal and written communication skills to serve as liaison between Cullinan and contract research organizations and other outward-facing partners
• Ability to excel in a fast-paced work environment with focus on multiple programs in parallel

Responsibilities

• Lead and oversee contract research organizations in discovery efforts
• Design and execute program strategy and research plans
• Develop budget forecasts for drug development programs
• Day-to-day oversight of external research efforts
• Deliver impactful presentations to share program updates and data with colleagues
• Oversee logistical management of Cullinan samples
• Lead internal technical discussions on preclinical programs
• Develop innovative strategies to move existing programs forward
• Lead internal innovation projects and generate ideas for new pipeline programs
• Routinely review relevant scientific literature and competitive landscape; attend scientific conferences
• Author/review regulatory submissions documents related to nonclinical IND-enabling studies
• Participate in diligence activities to support the evaluation of potential new assets for addition to Cullinan portfolio